Information  X 
Enter a valid email address
  Print          More announcements

Friday 11 June, 2021

JPMorgan Sec.Plc

UDG Healthcare Plc 38.5a amend

RNS Number : 7035B
JPMorgan Securities Plc
11 June 2021
 

Ap24

 

  AMENDMENT

FORM   38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1.  KEY   INFORMATION

 

Nameofexemptprincipaltrader

J.P. Morgan Securities Plc

Companydealtin

UDG Healthcare Plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 1)

€0.05 ordinary shares

Date of dealing

21 May 2021

 

2.  DEALINGS  (Note   2)

 

(a)  Purchases and sales

 

Total numberofrelevantsecuritiesacquired

Highestpricepaid (Note 3)

Lowest price paid

(Note 3)

471,179

10.4600 GBP

10.2200 GBP

 

 

Total numberofsecuritiesdisposed

Highestpricereceived (Note 3)

Lowestpricereceived

(Note 3)

989,376

10.4602 GBP

10.2200 GBP

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 4)

Numberofrelevantsecurities

(Note 5)

Priceperunit

(Note 3)

Equity Swap

Decrease Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Decrease Short

 

 

 

 

 

 

 

 

Increase Long

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Increase Short

 

 

 

 

 

 

 

Opening a Long Position

3,606

4,555

3,727

1,378

474

978

742

5,411

3,820

3,905

852

826

44,577

841

 

1,459

11,191

14,140

50,000

1,276

536,686

10

1,400

 

368

223

147

1,064

77

11,376

5

7,140

413

558

466

555

74

833

280

9

10,163

37,453

 

8,033

719

72,485

5,069

1,089

5,000

21,940

 

75,000

10.2301 GBP

10.2325 GBP

10.2381 GBP

10.2403 GBP

10.2406 GBP

10.2601 GBP

10.2649 GBP

10.2917 GBP

10.3593 GBP

10.4124 GBP

10.4503 GBP

10.4506 GBP

10.4541 GBP

10.4600 GBP

 

10.2198 GBP

10.2514 GBP

10.3987 GBP

10.4140 GBP

10.4250 GBP

10.4257 GBP

10.4595 GBP

10.4598 GBP

 

10.2299 GBP

10.2399 GBP

10.3200 GBP

10.3210 GBP

10.3347 GBP

10.3756 GBP

10.4100 GBP

10.4108 GBP

10.4130 GBP

10.4157 GBP

10.4260 GBP

10.4264 GBP

10.4294 GBP

10.4349 GBP

10.4394 GBP

10.4395 GBP

10.4595 GBP

10.4600 GBP

 

10.2210 GBP

10.2315 GBP

10.2361 GBP

10.3284 GBP

10.4007 GBP

10.4052 GBP

10.4512 GBP

 

10.4222 GBP

 

Ap25

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing,   selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varyingetc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, Europeanetc.

Expiry date

Option money paid/received perunit (Note 3)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 3)

 

 

 

 

 

3.   OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities 

under   any   option   referred   to   on   this   form   or   relating   to   the   voting   rights  or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. 

If   none,   this   should   be   stated.

 

 

 

 

 

 

Dateofdisclosure

11 June 2021

Contactname

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

UDG Healthcare Plc

Nature of connection (Note 6)

Financial adviser to CD&R Fund XI

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEBLGDLXGBDGBB

a d v e r t i s e m e n t